NED Medical is seeking to transform oncology embolization therapy from a palliative to a curative-intent treatment with the mission of improving outcomes for patients with unresectable tumors.
PMD Solutions is the maker of RespiraSense. RespiraSense transforms the measurement of a patient’s respiratory rate with continuous, innovative technology monitoring – improving the measurement and identification of deterioration, in real-time to help save lives.
RhinUS is a medical device developed to treat the root cause of chronic rhinosinusitis (CRS), a condition affecting more than 30M Americans. Conceived by two engineers at Harvard Medical School, RhinUS combines the ease of in-office treatments with lasting symptom relief for CRS patients.
RedCrow start-ups include:
Actuated Medical for SonoShield
For over 16 million Americans grappling with neurological conditions like stroke, Parkinson’s, and paralysis, a groundbreaking solution is on the horizon to lost restore function. Brain computer implants hold the promise of restoring lost function. But they have a major challenge because the human body treats these implants as foreign bodies which triggers a response that limits the implant’s working lifetime. Actuated Medical’s innovative SonoShield™ Defender uses precisely engineered sound waves to help minimize this foreign body response. Early testing is demonstrating the promise of SonoShield Defender to extend implant working lifetime.
Bio-Superior is developing therapeutics for the treatment of life-threatening respiratory disease based on a unique drug delivery platform. Our first drug candidate is for the treatment of lung inflammation in preterm infants, bronchopulmonary dysplasia. This is a serious unmet medical need that affects about 15,000 preterm infants and costs US Healthcare over $1B annually. Our drug delivery platform increases the spread of drug over tissue surfaces and promotes transport of the drug into the affected tissue. We expect that this technology will lead to valuable treatments for ARDS, COPD, adenocarcinoma, and other lung diseases.
MARAbio is a precision-medicine company whose mission is to detect and treat the biological basis of Maternal Autoantibody Related Autism (MARA).